Home / Levodopa, Decarboxylase Inhibitor and COMT Inhibitor / Italy
IT ATC N04BA03 · updated 2 Nov 2026
Levodopa, Decarboxylase Inhibitor and COMT Inhibitor shortage in Italy
Is there a Levodopa, Decarboxylase Inhibitor and COMT Inhibitor shortage in Italy?
Yes. As of 2 Nov 2026, 2 Levodopa, Decarboxylase Inhibitor and COMT Inhibitor products are reported short in Italy. No return date has been given. Main reason: manufacturing problem.
Also short in Spain, Czechia, Sweden. All countries.
Affected products in Italy
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | LEVODOPA/CARBIDOPA/ENTACAPONE MYLAN anticipated | MYLAN S.P.A. | 1 Jan 2027 | not given | Manufacturing problem Problemi produttivi |
| IT | LEVODOPA/CARBIDOPA/ENTACAPONE MYLAN anticipated | MYLAN S.P.A. | 1 Jan 2027 | not given | Manufacturing problem Problemi produttivi |
Source
AIFA (Italian Medicines Agency), licensed CC-BY 4.0. Official list. All shortages reported by marketing-authorisation holders, including medicines being withdrawn.